"Fatty Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D005227
|
| MeSH Number(s) |
D10.251
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatty Acids".
Below are MeSH descriptors whose meaning is more specific than "Fatty Acids".
This graph shows the total number of publications written about "Fatty Acids" by people in this website by year, and whether "Fatty Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 2 | 5 |
| 1999 | 0 | 2 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 4 | 6 |
| 2003 | 3 | 3 | 6 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 2 | 3 |
| 2006 | 4 | 1 | 5 |
| 2007 | 3 | 2 | 5 |
| 2008 | 2 | 2 | 4 |
| 2009 | 5 | 2 | 7 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 2 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 7 | 11 |
| 2014 | 3 | 4 | 7 |
| 2015 | 1 | 4 | 5 |
| 2016 | 7 | 4 | 11 |
| 2017 | 5 | 6 | 11 |
| 2018 | 6 | 4 | 10 |
| 2019 | 7 | 8 | 15 |
| 2020 | 8 | 6 | 14 |
| 2021 | 6 | 2 | 8 |
| 2022 | 2 | 9 | 11 |
| 2023 | 2 | 14 | 16 |
| 2024 | 2 | 5 | 7 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatty Acids" by people in Profiles.
-
Computational modeling of cancer cell metabolism along the catabolic-anabolic axes. NPJ Syst Biol Appl. 2025 May 10; 11(1):46.
-
G-protein coupled receptors in metabolic reprogramming and cancer. Pharmacol Ther. 2025 Jun; 270:108849.
-
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
-
Advancing de novo lipogenesis: Genetic and metabolic insights. Cell Metab. 2025 Jan 07; 37(1):3-4.
-
Oligodendroglial fatty acid metabolism as a central nervous system energy reserve. Nat Neurosci. 2024 Oct; 27(10):1934-1944.
-
Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD. Cell Rep Med. 2024 Sep 17; 5(9):101714.
-
Identifying the Leading Sources of Saturated Fat and Added Sugar in U.S. Adults. Nutrients. 2024 Jul 30; 16(15).
-
Bempedoic Acid Falls in Line. J Am Coll Cardiol. 2024 Jul 09; 84(2):163-164.
-
Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease. Cell Metab. 2024 Jul 02; 36(7):1619-1633.e5.
-
Suppression of hepatic ChREBP?-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH. Mol Metab. 2024 Jul; 85:101957.